Profile data is unavailable for this security.
About the company
AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.
- Revenue in SEK (TTM)43.04m
- Net income in SEK-59.30m
- Incorporated2000
- Employees--
- LocationAroCell AB (publ)Karlsbodavagen 39BROMMA 168 67SwedenSWE
- Phone+46 18503020
- Websitehttps://arocell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spago Nanomedical AB (publ) | 1.20m | -42.22m | 76.63m | 13.00 | -- | 1.81 | -- | 63.70 | -0.3818 | -0.3818 | 0.0115 | 0.1882 | 0.0093 | -- | 5.74 | 92,538.46 | -32.61 | -20.19 | -35.38 | -20.97 | 247.55 | -- | -3,509.81 | -4,853.45 | -- | -- | -- | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -27.75m | 77.97m | -- | -- | 0.2246 | -- | -- | -0.0984 | -0.0984 | 0.00 | 0.6946 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -13.84 | -- |
| Immunovia AB (publ) | 1.21m | -260.73m | 84.33m | 11.00 | -- | 1.93 | -- | 69.58 | -6.06 | -6.06 | 0.0276 | 0.9648 | 0.0075 | 58.23 | 14.96 | 110,181.80 | -160.93 | -41.33 | -194.89 | -44.24 | -5,523.76 | -7,553.76 | -21,512.13 | -20,879.29 | 2.03 | -- | 0.1675 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Bioextrax AB publ | 2.06m | -21.51m | 86.31m | -- | -- | 3.60 | -- | 41.96 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| Dextech Medical AB | 0.00 | -4.57m | 92.06m | 1.00 | -- | 2.85 | -- | -- | -0.2473 | -0.2473 | 0.00 | 1.75 | 0.00 | -- | -- | -- | -13.04 | -28.96 | -13.21 | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Ziccum AB | 3.75m | -21.41m | 92.23m | 8.00 | -- | 9.69 | -- | 24.62 | -1.54 | -1.54 | 0.2701 | 0.6191 | 0.1553 | -- | 2.01 | 468,375.00 | -88.74 | -68.51 | -109.73 | -76.47 | -- | -- | -571.44 | -2,598.03 | -- | -- | 0.0908 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
| Wntresearch AB | 0.00 | -32.47m | 94.83m | 2.00 | -- | 1.80 | -- | -- | -0.1108 | -0.1108 | 0.00 | 0.0609 | 0.00 | -- | -- | 0.00 | -134.85 | -100.71 | -166.68 | -123.59 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.65 | -- | -- | -- |
| Sprint Bioscience AB | 50.49m | -441.00k | 94.96m | 28.00 | -- | 3.42 | 13,565.05 | 1.88 | -0.0064 | -0.0064 | 0.7232 | 0.3978 | 1.01 | -- | 7.58 | 1,803,036.00 | -0.8838 | -71.22 | -1.58 | -113.71 | 82.77 | 62.75 | -0.8735 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Biosergen AB | 0.00 | -27.04m | 96.03m | 3.00 | -- | 8.29 | -- | -- | -0.4007 | -0.4007 | 0.00 | 0.0418 | 0.00 | -- | -- | 0.00 | -131.31 | -- | -217.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.25 | -- | -- | -- |
| AroCell AB (publ) | 43.04m | -59.30m | 99.06m | -- | -- | 0.6053 | -- | 2.30 | -0.2574 | -0.2574 | 0.1868 | 0.7104 | 0.2095 | 6.68 | 6.52 | -- | -28.86 | -29.25 | -30.70 | -31.37 | -4.38 | -9.85 | -137.78 | -231.19 | 5.25 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Opticept Technologies AB | 9.15m | -80.36m | 106.15m | 29.00 | -- | 0.2328 | -- | 11.61 | -2.62 | -2.62 | 0.2981 | 10.80 | 0.0213 | -0.0638 | 2.37 | 315,344.80 | -18.69 | -41.76 | -21.19 | -46.21 | 125.88 | 62.65 | -879.63 | -882.41 | 0.6163 | -14.16 | 0.0566 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.41m | 108.13m | 4.00 | -- | 17.04 | -- | -- | -0.1887 | -0.1887 | 0.00 | 0.0183 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Toleranzia AB | 0.00 | -7.46m | 110.36m | -- | -- | 0.7189 | -- | -- | -0.0597 | -0.0597 | 0.00 | 0.779 | 0.00 | -- | -- | -- | -5.21 | -7.45 | -5.43 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0055 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Bio-Works Technologies AB | 43.90m | -56.82m | 111.09m | 38.00 | -- | 2.52 | -- | 2.53 | -1.58 | -1.58 | 1.22 | 1.13 | 0.571 | 1.82 | 5.83 | 1,155,158.00 | -73.91 | -49.14 | -101.72 | -57.90 | 61.10 | 69.88 | -129.44 | -168.30 | 2.79 | -- | 0.00 | -- | 6.23 | 46.24 | -26.41 | -- | 1.95 | -- |
| Isofol Medical AB (publ) | 721.00k | -37.07m | 112.25m | 3.00 | -- | 0.9244 | -- | 155.69 | -0.233 | -0.233 | 0.0045 | 0.7518 | 0.0041 | -- | 0.0728 | 240,333.30 | -21.15 | -66.73 | -26.32 | -88.27 | -4,773.37 | -- | -5,141.61 | -1,023.62 | -- | -- | 0.00 | -- | -94.37 | -- | 76.80 | -- | -- | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 116.43m | -- | -- | 57.18 | -- | 142.27 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
Data as of May 06 2024. Currency figures normalised to AroCell AB (publ)'s reporting currency: Swedish Krona SEK
0.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Arvernus Capital AGas of 30 Sep 2023 | 440.49k | 0.19% |
Data from 30 Sep 2023 - 30 Sep 2023Source: FactSet Research Systems Inc.
